ARCHIVES

FDA Approves BMS’s Yervoy For Metastatic Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted

July 19, 1991

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

ACS, NBCC Weigh Involvement In March, Ask What Happens Next

October 31, 1997

DCCR Receives 59 Community Hospital Oncology Program Proposals, Only here From Rural Areas

September 21, 1979